Hybridoma cell strain secreting anti-maize chlorotic dwarf virus monoclonal antibody, secreted antibody, application and kit prepared from monoclonal antibody
A hybridoma cell line and dwarf virus technology, which is applied in antiviral immunoglobulin, analytical materials, and microbial-based methods, can solve the problems of complex operation, high cost, and high professional skill requirements for operators
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Benefits of technology
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0012] The hybridoma cell line MCDV secreting anti-maize chlorotic dwarf virus monoclonal antibody was preserved in the China Center for Type Culture Collection (CCTCC) (Wuchang Luo, Wuhan City, Hubei Province) on April 26, 2014. Jiashan, Wuhan University, Collection Center), the collection number is CCTCC No: C201486, it can secrete monoclonal antibody against maize chlorotic dwarf virus.
[0013] Anti-maize chlorotic dwarf virus monoclonal antibody ascitic fluid indirect ELISA titer reached 10 -7 , the antibody type and subclass are IgG 1 , kappa chain, the monoclonal antibody can have specific immunological binding reaction with the coat protein subunit of maize chlorotic dwarf virus.
[0014] Monoclonal antibodies against maize chlorotic dwarf virus have specific immune reactions only with maize chlorotic dwarf virus, but with rice tungro spherical virus (RTSV), maize dwarf mosaic virus (Maize dwarf mosaic Virus (MDMV), Maize rough dwarf Virus (MRDV), Maize chlorotic mottle
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap